IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies

Annals of the Rheumatic Diseases

Volumn 74, Issue 7, 2015, Pages 1425-1431

  Laurent, Lætitia ^a,b,c   Anquetil, Florence ^a,b,c,d   Clavel, Cyril ^a,b,c,d   Ndongo Thiam, Ndiémé ^e   Offer, Géraldine ^a,b,c   Miossec, Pierre ^e   Pasquali, Jean Louis ^f   Sebbag, Mireille ^a,b,c   Serre, Guy ^a,b,c,d  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b CNRS   (France)

^c University of Toulouse III   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e University of Lyon   (France)

^f INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA; ANTIGEN ANTIBODY COMPLEX; ANTIIDIOTYPIC ANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE SEVERITY; HUMAN; IN VITRO STUDY; MACROPHAGE; MOLECULAR PATHOLOGY; MONOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; CASE CONTROL STUDY; CELL CULTURE; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SYNOVIUM;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIGEN-ANTIBODY COMPLEX; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IN VITRO TECHNIQUES; INFLAMMATION; MACROPHAGES; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84934928354     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204543     Document Type: Article

References (56)

1. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
2. Mellors RC, Heimer R, Corcos J, et al. Cellular origin of rheumatoid factor. J Exp Med 1959;110:875-86.
3. McCormick JN. An immunofluorescence study of rheumatoid factor. Ann Rheum Dis 1963;22:1-10.
4. Fehr K, Velvart M, Rauber M, et al. Production of agglutinators and rheumatoid factors in plasma cells of rheumatoid and nonrheumatoid synovial tissues. Arthritis Rheum 1981;24:510-19.
5. Wernick RM, Lipsky PE, Marban-Arcos E, et al. IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures. Arthritis Rheum 1985;28:742-52.
6. Panush RS, Bittner AK, Sullivan M, et al. IgM rheumatoid factor elaboration by blood, bone marrow, and synovial mononuclear cells in patients with rheumatoid arthritis. Clin Immunol Immunopathol 1985;34:387-91.
7. Soden M, Whelan A, Feighery C, et al. Lymphocyte infiltration and the synthesis of IgM and IgA rheumatoid factors by rheumatoid synovial membrane. Rheumatol Int 1990;10:149-52.
8. Jasin HE. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1985;28:241-8.
9. Mochan E, Passon TJ Jr. Properties and reactivity of immune complexes in rheumatoid synovial fluid. Rheumatol Int 1986;6:103-9.
10. Zlabinger GJ, Haberhauer G, Dax K, et al. Rheumatoid factor isotypes and circulating immune complexes in rheumatoid arthritis. Clin Exp Rheumatol 1990;8:113-19.
11. Vander Cruyssen B, Cantaert T, Nogueira L, et al. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res Ther 2006;8:R122.
12. Schellekens GA, de Jong BA, van den Hoogen FH, et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81.
13. Girbal-Neuhauser E, Durieux JJ, Arnaud M, et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999;162:585-94.
14. Sebbag M, Moinard N, Auger I, et al. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 2006;36:2250-63.
15. Iobagiu C, Magyar A, Nogueira L, et al. The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted. J Autoimmun 2011;37:263-72.
16. Masson-Bessière C, Sebbag M, Durieux JJ, et al. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000;119:544-52.
17. Iwaki-Egawa S, Matsuno H, Ogawa Y, et al. Production of anti-CCP antibodies and matrix metalloproteinase-3 by human rheumatoid arthritis synovial tissues using SCID mice. Ann Rheum Dis 2005;64:1094-5.
18. Humby F, Bombardieri M, Manzo A, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009;6:59-75.
19. Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001;166:4177-84.
20. Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, et al. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002;29:2074-6.
21. Aho K, Heliovaara M, Maatela J, et al. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991;18:1282-4.
22. Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-6.
23. van Leeuwen MA, Westra J, van Riel PL, et al. IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression? Scand J Rheumatol 1995;24:146-53.
24. Paimela L, Palosuo T, Leirisalo-Repo M, et al. Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis. Br J Rheumatol 1995;34:1146-50.
25. Vencovsky J, Machacek S, Sedova L, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 2003;62:427-30.
26. De Rycke L, Peene I, Hoffman IE, et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 2004;63:1587-93.
27. Agrawal S, Misra R, Aggarwal A. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Clin Rheumatol 2007;26:201-4.
28. Syversen SW, Gaarder PI, Goll GL, et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2008;67:212-17.
29. Clavel C, Nogueira L, Laurent L, et al. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 2008;58:678-88.
30. Sabharwal UK, Vaughan JH, Fong S, et al. Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4. Arthritis Rheum 1982;25:161-7.
31. Robbins DL, Fiegal DW Jr, Leek JC, et al. Complement activation by 19S IgM rheumatoid factor: relationship to disease activity in rheumatoid arthritis. J Rheumatol 1986;13:33-8.
32. Sato Y, Sato R, Watanabe H, et al. Complement activating properties of monoreactive and polyreactive IgM rheumatoid factors. Ann Rheum Dis 1993;52:795-800.
33. Pasquali JL, Knapp AM, Farradji A, et al. Mapping of four light chain-associated idiotopes of a human monoclonal rheumatoid factor. J Immunol 1987;139:818-23.
34. Maini RN, Feldmann M. How does infliximab work in rheumatoid arthritis? Arthritis Res 2002;4(Suppl 2):S22-28.
35. Shibuya A, Sakamoto N, Shimizu Y, et al. Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol 2000;1:441-6.
36. Kubagawa H, Oka S, Kubagawa Y, et al. Identity of the elusive IgM Fc receptor (FcmuR) in humans. J Exp Med 2009;206:2779-93.
37. Mageed RA, Kirwan JR, Thompson PW, et al. Characterisation of the size and composition of circulating immune complexes in patients with rheumatoid arthritis. Ann Rheum Dis 1991;50:231-6.
38. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008;8:533-44.
39. Li J, Hsu HC, Mountz JD. Managing macrophages in rheumatoid arthritis by reform or removal. Curr Rheumatol Rep 2012;14:445-54.
40. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958-69.
41. Ambarus CA, Noordenbos T, de Hair MJ, et al. Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis. Arthritis Res Ther 2012;14:R74.
42. Ambarus CA, Krausz S, van Eijk M, et al. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J Immunol Methods 2012;375:196-206.
43. Sato Y, Watanabe H, Kogure A, et al. Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses. Clin Rheumatol 1995;14:425-8.
44. Trouw LA, Haisma EM, Levarht EW, et al. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum 2009;60:1923-31.
45. Kim JW, Wierda WG, Kim YB. Immobilized IgG immune complex induces secretion of tumor necrosis factor-alpha by porcine alveolar macrophages. Am J Respir Cell Mol Biol 1991;5:249-55.
46. DiMartino SJ, Yuan W, Redecha P, et al. Insoluble immune complexes are most effective at triggering IL-10 production in human monocytes and synergize with TLR ligands and C5a. Clin Immunol 2008;127:56-65.
47. Gupta S, Booth JW. ERK phosphorylation and tumor necrosis factor-alpha production by monocytes are persistent in response to immobilized IgG. Biochem Biophys Res Commun 2010;402:301-4.
48. Ambarus CA, Santegoets KC, van Bon L, et al. Soluble immune complexes shift the TLR-induced cytokine production of distinct polarized human macrophage subsets towards IL-10. PLoS ONE 2012;7:e35994.
49. Wines BD, Gavin A, Powell MS, et al. Soluble FcgammaRIIa inhibits rheumatoid factor binding to immune complexes. Immunology 2003;109:246-54.
50. Sasso EH, Barber CV, Nardella FA, et al. Antigenic specificities of human monoclonal and polyclonal IgM rheumatoid factors. The C gamma 2-C gamma 3 interface region contains the major determinants. J Immunol 1988;140:3098-107.
51. Corper AL, Sohi MK, Bonagura VR, et al. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nat Struct Biol 1997;4:374-81.
52. Duquerroy S, Stura EA, Bressanelli S, et al. Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation. J Mol Biol 2007;368:1321-31.
53. Schrohenloher RE. IgG as antigen in human rheumatoid disease. Scand J Rheumatol Suppl 1988;75:133-9.
54. Soltys AJ, Hay FC, Bond A, et al. The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand J Immunol 1994;40:135-43.
55. Parekh RB, Dwek RA, Sutton BJ, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985;316:452-7.
56. Scherer HU, van der Woude D, Ioan-Facsinay A, et al. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum 2010;62:1620-9.